title: Reply: To PMID 23389758.
authors.affiliation: Graduate Institute of Clinical Medicine, China Medical University, Taichung, Taiwan.
authors.forename: Yao-Chun
authors.initials: YC
authors.lastname: Hsu
authors.forename: Chun-Ying
authors.initials: CY
authors.lastname: Wu
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin